The liver cancer treatment sorafenib should not be available routinely in the NHS in England, but it should continue to be available through the Cancer Drugs Fund, the National Institute for Health...
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2j37gNA
via
IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου